Table 2

 Patient demographics and macular hole characteristics

Parameters (averages)Total (n = 30)ICG (n = 14)TB (n = 16)ICG v TB (t test)
*n = 12.
Age (years) (range)69.6 (54–82)70.7 (56–82)68.6 (54–81)p = 0.411
Number of female patients (%)22 (73.3%)10 (71.4%)12 (75.0%)
Duration between diagnosis and surgery (days) (range)286.1 (10–1855)317.3 (25–1855)258.8 (10–1718)p = 0.713
Follow up postop (months) (range)10.0 (1–30)10.6 (1–30)9.4 (1–27)p = 0.729
Stage of holes (number; %):
    Stage 29 (30.0%)6 (42.9%)3 (18.8%)
    Stage 316 (53.3%)6 (42.9%)10 (66.6%)
    Stage 45 (16.7%)2 (14.2%)3 (18.8%)
Average size of macular holes (μm) (range)407.1 (200–700)366.7* (200–700)437.5 (200–800)p = 0.270